Time to Extubation Among ARDS Subjects With and Without COVID-19 Pneumonia

Area of Science:

• Critical Care Medicine
• Pulmonology
• Infectious Diseases

Background:

• Pneumonia caused by COVID-19 can lead to Acute Respiratory Distress Syndrome (ARDS), often necessitating invasive mechanical ventilation.
• This study compares COVID-19-associated ARDS with non-COVID ARDS in terms of characteristics and outcomes.
• Focuses on the initial six months of the COVID-19 pandemic in 2020.

Purpose of the Study:

• To determine if mechanical ventilation duration differs between COVID-19-associated ARDS and non-COVID ARDS cohorts.
• To identify factors contributing to differences in mechanical ventilation duration.
• To compare patient characteristics and clinical outcomes between the two ARDS groups.

Main Methods:

• Retrospective analysis of 73 subjects requiring >48 hours of mechanical ventilation.
• Included patients with COVID-19-associated ARDS (n=37) and non-COVID ARDS (n=36).
• Utilized Wilcoxon rank-sum and chi-square tests for comparisons; Cox proportional hazards model for extubation analysis.

Main Results:

• Median mechanical ventilation duration was significantly longer for COVID-19 ARDS (10 days) versus non-COVID ARDS (4 days) in survivors (P < .001).
• Hospital mortality rates were similar between groups (22% vs 39%, P = .11).
• Improved respiratory system compliance and oxygenation predicted extubation; oxygenation improved slower in COVID-19 ARDS.

Conclusions:

• COVID-19-associated ARDS requires longer mechanical ventilation compared to non-COVID ARDS.
• Slower improvement in oxygenation status in COVID-19 ARDS patients may account for the prolonged ventilation duration.
• Findings highlight key differences in recovery trajectories between these ARDS types.